Its a ploy by the drug companies and the people they support to have
more stages for drug development and treatment.
Imagine the market if you can sell a drug to treat mild cognitive
impairment. The drug companies tried this before.
They called the disorder, age-associated cognitive impairment. The FDA
did not approve the trials here so they did
most of the research in Europe. These trials did not result in
significant results.
Mike Williams
Subject: Puzzling Alzheimers diagnosis
From: "michael sylvester"<msylves...@copper.net>
Date: Sun, 24 Apr 2011 16:12:32 -0100
X-Message-Number: 1
The new guidelines for evaluating Alzm distinguish among three stages,namely,a
pre-clinical.mild cognitive impairment,and dementia.It is the
pre-clinical(stage without symptoms) that I find puzzling.It would seem that if
there are no symptoms that condition does not deserve to be called a stage.Or
virtually all conditions will have a pre-clinical stage.I guess we are all in a
pre-clinical stage for developping schizophrenia. Come on,I can envision a
post-clinical stage,but pre-clinical?
Michael "omnicentric" Sylvester,PhD
Daytona Beach,Florida
---
You are currently subscribed to tips as: arch...@jab.org.
To unsubscribe click here:
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=10183
or send a blank email to
leave-10183-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu
